Cryoprecipitate is indicated for which condition?

Master the CAMLPR Transfusion Test with interactive questions and detailed explanations. Boost your knowledge and ensure you're exam-ready with comprehensive study resources!

Multiple Choice

Cryoprecipitate is indicated for which condition?

Cryoprecipitate is used to raise fibrinogen levels and provide several fibrin-related factors, making it the go-to product for hypofibrinogenemia and related coagulopathies. Its high fibrinogen content (factor I) along with factors VIII and XIII, plus von Willebrand factor, helps restore the clotting process when fibrinogen is deficient—such as in DIC, massive transfusion, or liver disease with low fibrinogen. It is not used for low platelets, so thrombocytopenia is treated with platelets rather than cryoprecipitate. It’s also not ideal for hemophilia B, which is a deficiency of factor IX and is treated with factor IX concentrates or appropriate plasma products. Vitamin K deficiency requires vitamin K and, if urgent replacement is needed, broader-factor-containing products like fresh frozen plasma rather than cryoprecipitate.

Cryoprecipitate is used to raise fibrinogen levels and provide several fibrin-related factors, making it the go-to product for hypofibrinogenemia and related coagulopathies. Its high fibrinogen content (factor I) along with factors VIII and XIII, plus von Willebrand factor, helps restore the clotting process when fibrinogen is deficient—such as in DIC, massive transfusion, or liver disease with low fibrinogen. It is not used for low platelets, so thrombocytopenia is treated with platelets rather than cryoprecipitate. It’s also not ideal for hemophilia B, which is a deficiency of factor IX and is treated with factor IX concentrates or appropriate plasma products. Vitamin K deficiency requires vitamin K and, if urgent replacement is needed, broader-factor-containing products like fresh frozen plasma rather than cryoprecipitate.

More practice questions